Advanced Proteome Financials
| APTCF Stock | USD 0.0002 0.00 0.00% |
Advanced |
Understanding current and past Advanced Proteome Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Advanced Proteome's financial statements are interrelated, with each one affecting the others. For example, an increase in Advanced Proteome's assets may result in an increase in income on the income statement.
Advanced Proteome Stock Summary
Advanced Proteome competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, and Anebulo Pharmaceuticals. Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. Advanced Proteome operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 8337 Eastlake Drive, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.advancedproteome.com |
| Phone | 604 690 3797 |
| Currency | USD - US Dollar |
Advanced Proteome Key Financial Ratios
There are many critical financial ratios that Advanced Proteome's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Advanced Proteome reports annually and quarterly.Advanced Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Advanced Proteome's current stock value. Our valuation model uses many indicators to compare Advanced Proteome value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Advanced Proteome competition to find correlations between indicators driving Advanced Proteome's intrinsic value. More Info.Advanced Proteome Therapeutics is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Advanced Proteome's earnings, one of the primary drivers of an investment's value.Advanced Proteome Systematic Risk
Advanced Proteome's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Advanced Proteome volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Advanced Proteome correlated with the market. If Beta is less than 0 Advanced Proteome generally moves in the opposite direction as compared to the market. If Advanced Proteome Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Advanced Proteome is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Advanced Proteome is generally in the same direction as the market. If Beta > 1 Advanced Proteome moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Advanced Pink Sheet analysis
When running Advanced Proteome's price analysis, check to measure Advanced Proteome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Proteome is operating at the current time. Most of Advanced Proteome's value examination focuses on studying past and present price action to predict the probability of Advanced Proteome's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Proteome's price. Additionally, you may evaluate how the addition of Advanced Proteome to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |